Department of Biochemistry, University of Kassel, Heinrich-Plett-Strasse 40, 34132 Kassel, Germany.
J Biol Chem. 2010 Nov 12;285(46):35910-8. doi: 10.1074/jbc.M110.155150. Epub 2010 Sep 6.
cAMP-dependent protein kinases are reversibly complexed with any of the four isoforms of regulatory (R) subunits, which contain either a substrate or a pseudosubstrate autoinhibitory domain. The human protein kinase X (PrKX) is an exemption as it is inhibited only by pseudosubstrate inhibitors, i.e. RIα or RIβ but not by substrate inhibitors RIIα or RIIβ. Detailed examination of the capacity of five PrKX-like kinases ranging from human to protozoa (Trypanosoma brucei) to form holoenzymes with human R subunits in living cells shows that this preference for pseudosubstrate inhibitors is evolutionarily conserved. To elucidate the molecular basis of this inhibitory pattern, we applied bioluminescence resonance energy transfer and surface plasmon resonance in combination with site-directed mutagenesis. We observed that the conserved αH-αI loop residue Arg-283 in PrKX is crucial for its RI over RII preference, as a R283L mutant was able to form a holoenzyme complex with wild type RII subunits. Changing the corresponding αH-αI loop residue in PKA Cα (L277R), significantly destabilized holoenzyme complexes in vitro, as cAMP-mediated holoenzyme activation was facilitated by a factor of 2-4, and lead to a decreased affinity of the mutant C subunit for R subunits, significantly affecting RII containing holoenzymes.
cAMP 依赖性蛋白激酶可与调节(R)亚基的四种同工型中的任意一种可逆地结合,而调节亚基包含底物或假底物自动抑制结构域。人蛋白激酶 X(PrKX)是一个例外,因为它仅被假底物抑制剂(即 RIα 或 RIβ)抑制,而不受底物抑制剂 RIIα 或 RIIβ 的抑制。详细研究了从人类到原生动物(非洲锥虫)的五种 PrKX 样激酶与人类 R 亚基在活细胞中形成全酶的能力,表明这种对假底物抑制剂的偏好是进化保守的。为了阐明这种抑制模式的分子基础,我们应用了生物发光共振能量转移和表面等离子体共振结合定点突变。我们观察到,PrKX 中保守的αH-αI 环残基 Arg-283 对其 RI 优于 RII 的偏好至关重要,因为 R283L 突变体能够与野生型 RII 亚基形成全酶复合物。改变 PKA Cα(L277R)中相应的αH-αI 环残基,显著降低了体外全酶复合物的稳定性,因为 cAMP 介导的全酶激活被促进了 2-4 倍,并且导致突变 C 亚基对 R 亚基的亲和力降低,显著影响包含 RII 的全酶。